Using the Illumina Infinium HumanMethylation 27 K array, two publications [6, 33] have proposed splitting the CIMP-N subtype into two groups, one of which is enriched for distal tumours and TP53 mutations, and the other enriched for rectal tumours with a low frequency of mutations. This evidence concerns the gene TP53 and rectal neoplasm.